Tirzepatide acts on both GLP-1 and GIP receptors, which increase insulin secretion, slow stomach emptying, decrease appetite, and improve glucose control
La cada de patentes en algunos pases ya permite la produccin de versiones genricas, y esto reduce los costos y ampla el acceso
4,19,20 Conclusion SGLT2 inhibitors used in the treatment of T2DM have a unique mechanism that specifically targets the kidneys
A shift in the speed at which food passes through the intestines can alter the environment in which gut bacteria thrive, potentially leading to dysbiosis
Before you start a GLP-1, increase the amount of fiber in your diet slowly
It is naturally produced by your body and supplementation simply replenishes and optimises levels